cycloheximide has been researched along with rocaglamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Addo, EM; Anaya-Eugenio, GD; Carcache de Blanco, EJ; Ezzone, N; Henkin, JM; Kinghorn, AD; Ninh, TN; Ren, Y; Soejarto, DD | 1 |
| Appleman, JR; Chen, J; Chiang, GG; Clarine, J; Eam, B; Ernst, JT; Fish, S; Howard, H; Michels, T; Molter, J; Nevarez, A; Nilewski, C; Packard, G; Reich, SH; Sperry, S; Sprengeler, PA; Staunton, J; Thompson, PA; Tran, C; Webster, KR; Wegerski, CJ; Xiang, A; Young, NP | 1 |
2 other study(ies) available for cycloheximide and rocaglamide
| Article | Year |
|---|---|
Caspase-Dependent Apoptosis in Prostate Cancer Cells and Zebrafish by Corchorusoside C from Streptocaulon juventas.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apocynaceae; Apoptosis; Caspases; Cell Line, Tumor; Humans; I-kappa B Kinase; Male; Molecular Structure; Poly (ADP-Ribose) Polymerase-1; Prostate; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Pyrans; Vietnam; Zebrafish | 2019 |
Design of Development Candidate eFT226, a First in Class Inhibitor of Eukaryotic Initiation Factor 4A RNA Helicase.
Topics: Animals; Benzofurans; Binding Sites; Breast Neoplasms; Cell Line, Tumor; Crystallography, X-Ray; Drug Design; Eukaryotic Initiation Factor-4A; Female; Half-Life; Humans; Ligands; Mice; Mice, Nude; Molecular Dynamics Simulation; Mutagenesis, Site-Directed; Protein Structure, Tertiary; Rats; RNA, Messenger; Structure-Activity Relationship | 2020 |